Cassava Sciences' Alzheimer's drug simufilam failed key trial endpoints, leading to a stock plunge. See why SAVA stock is at risk of delisting or merger.
Yoshi-P has been desperate to collaborate with Final Fantasy 7 Rebirth’s boss. He is the mastermind behind the long-running online RPG Final Fantasy 14. Final Fantasy 14 is one of the longest-running ...